Journal
PARKINSONISM & RELATED DISORDERS
Volume 23, Issue -, Pages 99-101Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2015.12.002
Keywords
Parkinson disease; Leukocyte; beta-Glucocerebrosidase; beta-hexosaminidase; Gaucher disease
Categories
Ask authors/readers for more resources
Background: Recent reports have shown that the activities of lysosomal enzymes are altered in the CNS of sporadic PD (sPD) without GBA mutations. We hypothesized that the activities of lysosomal enzymes are altered in peripheral blood leukocytes (PBLs) of patients with sPD and other genetic parkinsonism. Methods: Glucocerebrosidase and beta-hexosaminidase activities in PBLs were measured in 36 patients with sPD, 5 PD patients with PARK2 mutations, 10 patients with spinocerebellar ataxia (SCA) 17 with parkinsonism, and 20 healthy controls. Results: The glucocerebrosidase and beta-hexosaminidase activities were not different in patients with sPD, PD with PARK2 mutations, and SCA17 with parkinsonism from those of the controls. In the patients with sPD, the activity of GCase was positively correlated with disease duration. Conclusion: The glucocerebrosidase and beta-hexosaminidase activities in PBLs cannot be used as a biomarker in sPD and other genetic parkinsonism. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available